We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Tracker App Reveals Six Types of COVID-19 Infection

By HospiMedica International staff writers
Posted on 29 Jul 2020
Image: The COVID Symptom Study Smartphone application (Photo courtesy of Zoe Global)
Image: The COVID Symptom Study Smartphone application (Photo courtesy of Zoe Global)
A new study of data from a COVID-19 symptom-tracking app finds there are six distinct types of the disease, each with its own cluster of symptoms.

Researchers at King’s College London (KCL; United Kingdom), Lund University (Sweden), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a study that examined time series clustering of symptom presentation that was performed on data derived from a training dataset of completed cases, as collected from the COVID Symptom Study Smartphone application, developed by Zoe Global.

The study, which was published on June 12, 2020, in medRxiv, identified six types of COVID-19:
• 'Flu-like' with no fever: Headache, loss of smell, muscle pains, cough, sore throat, chest pain, no fever.
• 'Flu-like' with fever: Headache, loss of smell, cough, sore throat, hoarseness, fever, loss of appetite.
• Gastrointestinal: Headache, loss of smell, loss of appetite, diarrhea, sore throat, chest pain, no cough.
• Severe level one, fatigue: Headache, loss of smell, cough, fever, hoarseness, chest pain, fatigue.
• Severe level two, confusion: Headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain.
• Severe level three, abdominal and respiratory: Headache, loss of smell, loss of appetite, cough, fever, hoarseness, sore throat, chest pain, fatigue, confusion, muscle pain, shortness of breath, diarrhea, abdominal pain.

“Patients with level four, five, and six types were more likely to be admitted to hospital and more likely to need respiratory support,” concluded co-lead author Claire Steves, MD, of KCL, and colleagues. “If you can predict who these people are at day five, you have time to give them support and early interventions such as monitoring blood oxygen and sugar levels, and ensuring they are properly hydrated.”

Besides cough, fever, and loss of smell, often highlighted as three key symptoms of COVID-19, app data showed others symptoms, including headaches, muscle pains, fatigue, diarrhea, confusion, loss of appetite, and shortness of breath.

Related Links:
King’s College London
Lund University
Massachusetts General Hospital
Zoe Global


Gold Member
CPAP Ventilator
Somnus DM18
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
New
Syringes
Prefilled Saline Flush Syringes

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more